-
DDRI-18
- names:
3,3'-[6,6'-Bi-1H-Benzimidazole]-2,2'-diylbis-benzenamine
- CAS号:
4402-18-0
MDL Number: - MF(分子式): C26H20N6 MW(分子量): 416.488
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | DDRI-18 |
| 英文别名 | DDRI-18; DDRI18; DDRI 18 |
| CAS号 | 4402-18-0 |
| Inchi | InChI=1S/C26H20N6/c27-19-5-1-3-17(11-19)25-29-21-9-7-15(13-23(21)31-25)16-8-10-22-24(14-16)32-26(30-22)18-4-2-6-20(28)12-18/h1-14H,27-28H2,(H,29,31)(H,30,32) |
| InchiKey | QROWVLFOWUYBIG-UHFFFAOYSA-N |
| 分子式 Formula | C26H20N6 |
| 分子量 Molecular Weight | 416.488 |
| 溶解度Solubility | |
| 性状 | Solid powder |
| 储藏条件 Storage conditions | Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years). |
| 产品说明 | DDRI-18(CAS:4402-18-0):仅限应用于工业或者科学研究过程中非医疗目的,不应用于人类或动物的临床诊断以及治过程疗,该产品非药用,非食用。 |
| Introduction | DDRI-18 is an inhibitor of nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, enhancing the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin. |
| Application1 | |
| Application2 | |
| Application3 |
| [1]Jun DW, Jeong YS, Kim HJ, Jeong KC, Kim S, Lee CH. Characterization of DDRI-18 (3,3'-(1H,3'H-5,5'-bibenzo[d]imidazole-2,2'-diyl)dianiline), a novel small molecule inhibitor modulating the DNA damage response. Br J Pharmacol. 2012 Sep;167(1):141-50. doi: 10.1111/j.1476-5381.2012.01977.x. PubMed PMID: 22519567; PubMed Central PMCID: PMC3448919. |
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


